Informationen:
Fehler:
ID
28927
Beschreibung
Study Evaluating PPM-204 In Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00425919
Link
https://clinicaltrials.gov/show/NCT00425919
Stichworte
Versionen (1)
- 16.02.18 16.02.18 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
16. Februar 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Diabetes Mellitus NCT00425919
Eligibility Diabetes Mellitus NCT00425919
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Diabetes Mellitus NCT00425919
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Childbearing Potential Absent | Age
Item
men and women of non-childbearing potential, 18 to 70 years old
boolean
C3831118 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2])
C0332197 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2])
Diet therapy | Remedial exercise | Antidiabetic Oral Single
Item
subjects currently treated with diet and exercise alone and subjects receiving a single oral antidiabetic medication
boolean
C0012159 (UMLS CUI [1])
C0203988 (UMLS CUI [2])
C0935929 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C0205171 (UMLS CUI [3,3])
C0203988 (UMLS CUI [2])
C0935929 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C0205171 (UMLS CUI [3,3])
Body mass index
Item
bmi > 23 and < 43
boolean
C1305855 (UMLS CUI [1])
Antidiabetics Therapeutic procedure | Glucohemoglobin measurement
Item
for subjects currently treated with 1 antidiabetic medication: hba1c is greater than or equal to 6.8% and less than or equal to 8.5%.
boolean
C0935929 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0202054 (UMLS CUI [2])
C0087111 (UMLS CUI [1,2])
C0202054 (UMLS CUI [2])
Antidiabetics Therapeutic procedure Absent | Glucohemoglobin measurement
Item
for subjects not currently treated with antidiabetic medications: hba1c is greater than or equal to 7.2% and less than or equal to 9.0%
boolean
C0935929 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0202054 (UMLS CUI [2])
C0087111 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0202054 (UMLS CUI [2])
Patient need for Insulin regime
Item
subjects requiring insulin therapy
boolean
C0686904 (UMLS CUI [1,1])
C0557978 (UMLS CUI [1,2])
C0557978 (UMLS CUI [1,2])
Antidiabetics Oral Quantity
Item
subjects currently receiving 2 or more oral antidiabetic medications
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C1527415 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Patient need for CORTICOSTEROIDS FOR SYSTEMIC USE | Exception Procedure discontinued (treatment)
Item
subjects requiring systemic corticosteroids, unless treatment was discontinued at least 4 weeks before the screening visit
boolean
C0686904 (UMLS CUI [1,1])
C3653708 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0520253 (UMLS CUI [2,2])
C3653708 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0520253 (UMLS CUI [2,2])
Warfarin
Item
subjects receiving warfarin
boolean
C0043031 (UMLS CUI [1])
Thiazolidinediones | Exception Procedure discontinued (treatment)
Item
subjects currently receiving thiazolidinediones, unless treatment was discontinued 8 weeks before the screening visit
boolean
C1257987 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0520253 (UMLS CUI [2,2])
C1705847 (UMLS CUI [2,1])
C0520253 (UMLS CUI [2,2])
Complications of Diabetes Mellitus | Retinal Diseases | Kidney Diseases | Neuropathy Symptomatic
Item
significant diabetic complications (retinopathy, nephropathy, symptomatic neuropathy)
boolean
C0342257 (UMLS CUI [1])
C0035309 (UMLS CUI [2])
C0022658 (UMLS CUI [3])
C0442874 (UMLS CUI [4,1])
C0231220 (UMLS CUI [4,2])
C0035309 (UMLS CUI [2])
C0022658 (UMLS CUI [3])
C0442874 (UMLS CUI [4,1])
C0231220 (UMLS CUI [4,2])